Haqq Christopher has filed 5 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 25400 shares of Elicio Therapeutics, Inc. ($ELTX) on February 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Elicio Therapeutics, Inc. | $ELTX | Haqq Christopher | See Remarks | A | Common Stock | 25400 | $0.00 | 57,381.0000 | 17,489,516 | 79.42% | 0.15% |
| Feb. 2, 2026 | Elicio Therapeutics, Inc. | $ELTX | Haqq Christopher | See Remarks | A | Stock Option (Right to Buy) | 50900 | $0.00 | 50,900.0000 | 17,489,516 | 9999.99% | 0.29% |
| Feb. 3, 2025 | Elicio Therapeutics, Inc. | $ELTX | Haqq Christopher | See Remarks | A | Stock Option (Right to Buy) | 44000 | $0.00 | 44,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 30, 2024 | Elicio Therapeutics, Inc. | $ELTX | Haqq Christopher | See Remarks | A | Stock Option (Right to Buy) | 28200 | $0.00 | 28,200.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Elicio Therapeutics, Inc. | $ELTX | Haqq Christopher | See Remarks | A | Stock Option (right to buy) | 28200 | $0.00 | 28,200.0000 | 0 | 9999.99% | 0.00% |